单纯二氧化碳血管造影在破裂性主动脉瘤腔内修复术中的初步研究
本研究自2021年起连续纳入8例伴失血性休克的破裂性腹主动脉瘤患者,在局部麻醉下完全使用二氧化碳(CO2)行急诊腔内修复术(EVAR)。技术成功率100%,30天死亡率为25%(n=2),术后急性肾损伤仅发生于这2例死亡患者;作者认为该技术可行且安全,但需进一步研究确定CO2能否提高生存率并限制肾功能不全进展。
要点
- 8例伴失血性休克的rAAA患者完全使用CO2行急诊EVAR,技术成功率为100%。
- 30天死亡率为25%(n=2),术后急性肾损伤仅发生于这2例死亡患者。
- 作者认为完全使用CO2行rAAA的EVAR技术上可行且安全,但需进一步研究。
核心结论
- 完全使用CO2作为对比剂行破裂性腹主动脉瘤腔内修复术技术上可行且安全。
- 需进一步研究以确定CO2能否提高rAAA腔内修复术后的生存率并限制肾功能不全的进展。
研究设计与样本
- 自2021年起,连续纳入伴失血性休克且解剖条件适合标准覆膜支架的破裂性腹主动脉瘤患者,采用自动CO2注射器(Angiodroid SpA,San Lazzaro di Savena,意大利)完全使用CO2行急诊EVAR。
- 共完成8例经皮EVAR,均在局部麻醉下进行;中位年龄78岁(四分位距[IQR]=6),其中5例为男性。
主要发现
- 技术成功率为100%,30天死亡率为25%(n=2),中位CO2用量为400 ml(IQR=60)。
- 血清肌酐水平从入院至术后中位变化为升高0.14 mg/dL,从入院至30天中位变化为降低0.11 mg/dL。
- 术后急性肾损伤发生于2例死亡患者。
- 全部6例存活患者均显示瘤囊缩小>5 mm,中位随访10个月期间无再干预。
局限性
- 需进一步研究以确定CO2能否提高rAAA腔内修复术后的生存率并限制肾功能不全的进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Endovascular aortic repair (EVAR) of a ruptured abdominal aortic aneurysm (rAAA) has become a common approach. Hemorrhagic shock associated with the use of iodinated contrast medium (ICM) increases the risk of acute kidney injury (AKI). Theoretically, eliminating ICM from EVAR can decrease that risk. The aim of this pilot study was to analyze the feasibility and safety of emergent EVAR performed with the exclusive use of carbon dioxide (CO2) for a rAAA. METHODS: Since 2021, all consecutive rAAAs with hemorrhagic shock and suitable anatomical criteria for a standard endograft have been treated by EVAR with the exclusive use of CO2 using an automated CO2 injector (Angiodroid SpA, San Lazzaro di Savena, Italy). RESULTS: Eight percutaneous EVARs were performed under local anesthesia. Median age was 78 (interquartile range [IQR]=6) years, 5 patients were male. The technical success was 100%, the 30-day mortality was 25% (n=2), the median amount of administered CO2 was 400 (IQR=60) ml. The median change in serum creatinine level between admission, post-operative and 30-day values was an increase of 0.14 mg/dL and a decrease of 0.11 mg/dL, respectively. Post-operative AKI occurred in the two patients who died. All 6 surviving patients showed sac shrinkage >5 mm, and no reinterventions at a median follow-up of 10 months. CONCLUSIONS: Endovascular repair of rAAA with the exclusive use of CO2 as contrast agent is technically feasible and safe. Further studies are needed to determine whether CO2 increases survival rate and limits the progression of renal dysfunction after endovascular repair of rAAA.Clinical ImpactThe recorded rate of post-operative AKI after endovascular repair of rAAA performed with the use of CO2 found in this pilot study was significantly lower than the one reported in the literature with the use of ICM. Our hyphotesis is that the use of CO2 during rEVAR might increase survival rate and limits the progression of renal dysfunction.
引用
- Massaini G, Lazzarotto T, Masciello F, et al. A Pilot Study of Endovascular Repair for Ruptured Aortic Aneurysms With the Use of Carbon Dioxide Angiography Alone. J Endovasc Ther. 2023. PMID: 37309127. doi:10.1177/15266028231180995
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。